Centralizing your health system’s approach to environmental monitoring for pharmaceutical compounding can yield a host of benefits, not the least of which is helping your facility better respond to the additional requirements of USP Chapter <797>.
When the long-awaited, updated chapter was officially published on Nov. 1, 2022 (see “Stakeholders Share Their USP Compliance Journey,” Pharmacy Practice News, December 2022, page 1), it expanded the schedule for